NCT04022317View on ClinicalTrials.gov

Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

September 15, 2019

Study Completion Date

September 20, 2019

Conditions
Healthy Volunteer
Interventions
BIOLOGICAL

Biocon Insulin R

Biocon Insulin R is a short-acting human insulin, produced by recombinant deoxyribonucleic acid (rDNA) technology utilizing Pichia pastoris (yeast).

BIOLOGICAL

Humulin®R

Humulin® R is a polypeptide hormone structurally identical to human insulin synthesised through recombinant deoxyribonucleic acid (rDNA) technology in a non-pathogenic laboratory strain of Escherichia coli bacteria.

Trial Locations (1)

Unknown

Profil Mainz GmbH, Mainz

All Listed Sponsors
collaborator

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

lead

Biocon Limited

INDUSTRY

NCT04022317 - Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R | Biotech Hunter | Biotech Hunter